rs143537386

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 4P and 8B. PM1PM2BP6_Very_Strong

The NM_000548.5(TSC2):​c.2565C>A​(p.His855Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H855P) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)

Consequence

TSC2
NM_000548.5 missense

Scores

1
10
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.245

Publications

3 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
  • lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 8 benign, 35 uncertain in NM_000548.5
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 16-2075818-C-A is Benign according to our data. Variant chr16-2075818-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 663457.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSC2NM_000548.5 linkc.2565C>A p.His855Gln missense_variant Exon 23 of 42 ENST00000219476.9 NP_000539.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSC2ENST00000219476.9 linkc.2565C>A p.His855Gln missense_variant Exon 23 of 42 5 NM_000548.5 ENSP00000219476.3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000400
AC:
1
AN:
250298
AF XY:
0.00000737
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000886
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Tuberous sclerosis 2 Benign:1
Jul 07, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Jan 31, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Uncertain
-0.030
CADD
Benign
12
DANN
Benign
0.95
DEOGEN2
Uncertain
0.79
D;.;.;.;.;.;.;.;.;.;.;.;D;.;D
Eigen
Benign
-0.72
Eigen_PC
Benign
-0.81
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.72
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
M_CAP
Pathogenic
0.39
D
MetaRNN
Uncertain
0.47
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.048
D
MutationAssessor
Uncertain
2.6
M;.;.;.;M;M;.;.;.;M;.;M;.;.;.
PhyloP100
0.24
PrimateAI
Uncertain
0.51
T
PROVEAN
Uncertain
-3.2
D;.;.;D;.;D;.;.;D;D;.;.;.;.;D
REVEL
Uncertain
0.62
Sift
Benign
0.13
T;.;.;T;.;T;.;.;T;T;.;.;.;.;T
Sift4G
Benign
0.067
T;.;.;T;.;T;.;.;T;T;.;.;.;.;T
Polyphen
0.0010
B;.;.;.;D;D;.;.;D;B;.;.;.;.;.
Vest4
0.37
MutPred
0.47
Loss of methylation at R852 (P = 0.2363);Loss of methylation at R852 (P = 0.2363);Loss of methylation at R852 (P = 0.2363);.;Loss of methylation at R852 (P = 0.2363);Loss of methylation at R852 (P = 0.2363);Loss of methylation at R852 (P = 0.2363);Loss of methylation at R852 (P = 0.2363);.;Loss of methylation at R852 (P = 0.2363);Loss of methylation at R852 (P = 0.2363);Loss of methylation at R852 (P = 0.2363);Loss of methylation at R852 (P = 0.2363);Loss of methylation at R852 (P = 0.2363);.;
MVP
0.90
ClinPred
0.60
D
GERP RS
-1.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.34
gMVP
0.38
Mutation Taster
=31/69
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143537386; hg19: chr16-2125819; API